Deprescription on oncological palliative care: an integrating review
Background: Patients on oncologic palliative care (OPC), due to diverse symptomatology and variable severity, tend to present polypharmacy that, although it seems justifiable in many cases, can pose health risks and negative consequences on patients’ quality of life. Thus, it is necessary to evalua...
Guardado en:
Autores principales: | Ana P. Antonio, Maria B. Silva, Mariana F. Souza, Maria F. Barbosa |
---|---|
Formato: | article |
Lenguaje: | EN PT |
Publicado: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/72ab9045ce7144e6b8f050f58805664f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Solid Lipid Nanoparticles: An Approach to Improve Oral Drug Delivery
por: Nestor Mendoza-Muñoz, et al.
Publicado: (2021) -
The Lymphatic System: A Sometimes-Forgotten Compartment in Pharmaceutical Sciences
por: Malaz Yousef, et al.
Publicado: (2021) -
Abstracts of poster presentations at the 2021 virtual annual of the Canadian Society for Pharmaceutical Sciences.
por: Kristine Warman
Publicado: (2021) -
Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract
por: Yusuke Tanaka, et al.
Publicado: (2021) -
Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities
por: Matthias Shona Roost, et al.
Publicado: (2021)